About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Aug 04, 2022... REHOVOT, ISRAEL—August 4, 2022—The myriads of microbes in our gut, collectively termed the microbiome, are considered important to our health, but they can also harbor bacteria that contribute to inflammatory bowel disease or other disorders. Currently, however, it is impossible to target such disease-contributing bacteria without harming the surrounding beneficial microbes. Antibiotics kill friendly microbes along with the harmful ones, and in any event, they tend to trigger bacterial resistance and to have side effects. In a study published today in Cell, Weizmann Institute of Science researchers have demonstrated the feasibility of a potential therapy for killing inflammation-causing gut bacteria in a targeted manner: by using viruses that infect them.
Dec 05, 2022...
There is no cure for Crohn’s disease or ulcerative colitis, the two chronic inflammatory bowel diseases (IBD) that cause flareups of abdominal pain, diarrhea, fatigue, weight loss and even malnutrition.
Ulcerative colitis affects only the colon, while Crohn’s can attack any part of the digestive system.
Although scientists debate whether IBD is an autoimmune disorder, they agree that the painful inflammation is caused by an abnormal immune response to lifestyle triggers (such as diet) and environmental triggers (such as bacteria).
©2023 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR
